Diebold Nixdorf, Incorporated
DBD
$67.40
-$0.60-0.88%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.69B | 3.67B | 3.70B | 3.75B | 3.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.69B | 3.67B | 3.70B | 3.75B | 3.80B |
| Cost of Revenue | 2.75B | 2.74B | 2.76B | 2.80B | 2.86B |
| Gross Profit | 940.20M | 934.10M | 935.40M | 947.80M | 936.20M |
| SG&A Expenses | 559.90M | 556.00M | 550.00M | 549.90M | 553.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.50M | -1.10M | -3.00M | -2.30M | 1.30M |
| Total Operating Expenses | 3.39B | 3.38B | 3.40B | 3.44B | 3.51B |
| Operating Income | 297.60M | 291.50M | 300.30M | 311.20M | 291.90M |
| Income Before Tax | 71.00M | 27.90M | 57.20M | 49.80M | 59.30M |
| Income Tax Expenses | 17.70M | 38.00M | 65.20M | 64.30M | 57.30M |
| Earnings from Continuing Operations | 53.30 | -10.10 | -8.00 | -14.50 | 2.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.70M | -2.80M | -2.20M | -2.00M | -1.80M |
| Net Income | 50.60M | -12.90M | -10.20M | -16.50M | 200.00K |
| EBIT | 297.60M | 291.50M | 300.30M | 311.20M | 291.90M |
| EBITDA | 437.70M | 430.50M | 438.30M | 448.60M | 427.30M |
| EPS Basic | 1.38 | -0.34 | -0.27 | -0.44 | 0.01 |
| Normalized Basic EPS | 2.55 | 2.15 | 2.55 | 2.71 | 2.69 |
| EPS Diluted | 1.37 | -0.34 | -0.28 | -0.44 | 0.00 |
| Normalized Diluted EPS | 2.53 | 2.15 | 2.55 | 2.71 | 2.68 |
| Average Basic Shares Outstanding | 148.90M | 150.00M | 150.40M | 150.40M | 150.40M |
| Average Diluted Shares Outstanding | 149.70M | 150.30M | 150.50M | 150.50M | 150.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |